12 results
6-K
EX-99.2
IFRX
InflaRx N.V.
1 Nov 23
Current report (foreign)
8:04am
regulatory and ethics approvals to conduct the study and expect to start the trial by enrolling patients in the United States, Europe and selected other
6-K
EX-99.2
IFRX
InflaRx N.V.
10 Aug 23
Report of Foreign Private Issuer
8:00am
activities for the study, including selection of clinical trial sites, obtaining regulatory and ethics approvals to conduct the study and expect to start
6-K
vafxpsvdt5
24 Feb 21
Current report (foreign)
4:16pm
20-F/A
ucmczqf6pna7s
29 Mar 19
Annual report (foreign) (amended)
4:23pm
424B4
rrds2jou5t0jm2a5
7 May 18
Prospectus supplement with pricing info
4:47pm
F-1
9olyagqd7s6clga2h
2 May 18
Registration statement (foreign)
7:10am
20-F
nyk5r
29 Mar 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next